»¶Ó­À´µ½Öйú»¯Ñ§»á¹Ù·½ÍøÕ¾£¡

·ÃÎÊаæÍøÕ¾ | ¹ØÓÚÎÒÃÇ

ËùÔÚλÖãºÖйú»¯Ñ§»á > »áÒéרÌâ > Öйú»¯Ñ§»áµÚ30½ìѧÊõÄê»á

Äê»á±¨¸æÈÕ³Ì±í¡¡ ÏÂÔØ£ºÖйú»¯Ñ§»áµÚ30½ìѧÊõÄê»áÈÕ³ÌÊÖ²á.pdf

»áÒéÃû³Æ£ºÖйú»¯Ñ§»áµÚ30½ìѧÊõÄê»á
·Ö»áÃû³Æ£ºµÚ¶þÊ®Îå·Ö»á£º»¯Ñ§ÐÅϢѧÓ뻯ѧ¼ÆÁ¿Ñ§
¡¡×¢£ºPL-´ó»áÌØÑû±¨¸æ(Plenary Lecture) I-·Ö»áÑûÇ뱨¸æ(Invited) O-¿ÚÍ·±¨¸æ(Oral) P-ǽ±¨(Poster) A-×ÔÓɽ»Á÷
2016-07-02
»á³¡£º×ۺϽÌѧ2ºÅÂ¥B305 Ö÷³ÖÈË£ºÎ⺣Áú£¬ÖìάÁ¼
09:00-09:2525-I-001½¯»ªÁ¼Ò©ÎïÉè¼ÆµÄ»úÓöÓëÌôÕ½Ìí¼Óµ½ÎÒµÄÈÕ³Ì
09:25-09:5025-I-002Ðì¾þ¾«×¼Ò½Ñ§Ñо¿ÖеĻ¯Ñ§ÐÅϢѧËã·¨ÎÊÌâÌí¼Óµ½ÎÒµÄÈÕ³Ì
09:50-10:0525-I-003Áõ»ÀÏãPrion¹Ø¼üÍ»±ä¶ÔÆä½á¹¹¼°¾Û¼¯¹ý³ÌÓ°ÏìµÄ·Ö×ÓÄ£ÄâÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-10:2025-O-001È«ÀöÄȰÐÏòhPD-1µÄ¶àëÄÒÖÖÆ¼ÁµÄÉè¼Æ¼°ÆÀ¼ÛÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:20-10:3525-O-002ÀP-Ìǵ°°×µÄ½á¹¹¼°¹¦ÄÜÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
»á³¡£º×ۺϽÌѧ2ºÅÂ¥B305 Ö÷³ÖÈË£º½¯»ªÁ¼£¬Ðì ¾þ
10:50-11:1525-I-004ÖìάÁ¼µ°°×ÖÊ´ó¹æÄ£¹¹Ïó±ä»¯µÄ¼ÆËãÄ£ÄâÌí¼Óµ½ÎÒµÄÈÕ³Ì
11:15-11:4025-I-005ÌÆÚS»¯ºÏÎïDZÔÚhERG¶¾ÐԵļÆËã»úÔ¤²âÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
11:40-11:5525-O-003ÕÅÖñÇà´ÓÍ·Éè¼Æµ°°×ÖÊÕÛµþµÄÄ£ÄâÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
11:55-12:1025-O-004ѦΰΰÐÂÐÍHIV-1ÕûºÏøÓëÄæ×ªÂ¼Ã¸Ë«°ÐµãÒÖÖÆ¼Á½áºÏģʽ¼°ÄÍÒ©ÐÔµÄÔ¤²âÌí¼Óµ½ÎÒµÄÈÕ³Ì
»á³¡£º×ۺϽÌѧ2ºÅÂ¥B305 Ö÷³ÖÈË£ºÄßÓÀÄ꣬Íò ¼á
13:30-13:5525-I-006ÉÛѧ¹ãοؽüºìÍâ¹âÆ×Ó뻯ѧ¼ÆÁ¿Ñ§·½·¨Ñо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
13:55-14:2025-I-007ÄßÓÀÄêʳƷ°²È«ºÍ¼ì²âÖеĻ¯Ñ§¼ÆÁ¿Ñ§Ó¦ÓÃÌí¼Óµ½ÎÒµÄÈÕ³Ì
14:20-14:3525-O-005ÁõÅÎÅÎÌ«ºÕ×ÈʱÓò¹âÆ×½áºÏÆ«×îС¶þ³Ë¶Ô²»Í¬É³Ô´µØÑùÆ··ÖÀàµÄÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
14:35-14:5025-O-006ÕÅÐÀ»ùÓں˴ʲÕñµÄ´úл×éѧ·½·¨½áºÏ¶àÔªÇúÏß·Ö±æÌ½Ë÷Ðļ¡È±ÑªµÄÉúÎï±ê¼Ç Ìí¼Óµ½ÎÒµÄÈÕ³Ì
14:50-15:0525-O-007ÒüСÀö¾²Ì¬ÈýάУÕýÓ붯̬ËÄάУÕýÄ£ÐÍÓÃÓÚ¶¯Ì¬¸´ÔÓÌåϵÖжàÄ¿±êÎïʵʱ¶¨Á¿·ÖÎöµÄ±È½ÏÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
»á³¡£º×ۺϽÌѧ2ºÅÂ¥B305 Ö÷³ÖÈË£ºÌÆ ÚS£¬²ÌÎÄÉú
15:20-15:4525-I-008Ö£Ã÷ÔÂÊý¾ÝÇý¶¯µÄÒ©ÎïÉè¼Æ·½·¨Ñ§Ñо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
15:45-16:1025-I-009Åá½£·æ°ÐÏò¶¾Ëص°°×HipAµÄÒÖÖÆ¼ÁÄܹ»¼õÇáϸ¾úµÄ¶àÒ©ÄÍÒ©ÐÔÌí¼Óµ½ÎÒµÄÈÕ³Ì
16:10-16:3525-I-010Íò¼áDOXÔ¤²âÉúÎï´ó·Ö×ÓÓëÅäÌå½áºÏ¹¹ÏóÑо¿µÄнøÕ¹Ìí¼Óµ½ÎÒµÄÈÕ³Ì
16:35-17:0025-I-011²ÌÎÄÉú´ó»·Ö÷Ìå·Ö×ÓÖеķ­×ªÔ˶¯Ìí¼Óµ½ÎÒµÄÈÕ³Ì
17:00-17:1525-O-008¼ÍÏþ²¨Ö§³ÖÏòÁ¿»Ø¹éÓÃÓÚPbnmÐ͸ÆîÑ¿ó²ÄÁÏ·´Ìú´ÅÏàת±äζȵÄÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
17:15-17:3025-O-009Ê¢´ºÈªDiscovery of Multi-targeting Antitumor AgentÌí¼Óµ½ÎÒµÄÈÕ³Ì
17:30-17:4525-O-010Ðì¿¡ÃÀÒ»ÖÖ»ùÓÚÍøÂ繦ÄÜÄ£¿é»®·ÖµÄвßÂÔÓÃÓÚ°©Ö¢·ÖÆÚÔ¤²âÌí¼Óµ½ÎÒµÄÈÕ³Ì
17:45-18:0025-O-011ÀîæÌAutoT&T v2:Ò»ÖÖ¸ßЧ¶à¹¦ÄܵÄÏȵ¼½á¹¹Éú³ÉÓëÓÅ»¯¹¤¾ßÌí¼Óµ½ÎÒµÄÈÕ³Ì
2016-07-03
»á³¡£º×ۺϽÌѧ2ºÅÂ¥B305 Ö÷³ÖÈË£ºÀ´Â³»ª£¬ºîÍ¢¾ü
09:00-09:2525-I-012À´Â³»ª»ùÓÚϵͳÉúÎïѧµÄÒ©ÎïÉè¼ÆÌí¼Óµ½ÎÒµÄÈÕ³Ì
09:25-09:5025-I-013ºîÍ¢¾üÃæÏòCADDµÄ»ù´¡¿âMORTµÄÉè¼ÆºÍ¿ª·¢Ìí¼Óµ½ÎÒµÄÈÕ³Ì
09:50-10:0525-I-014ÍõÈÎСImproved Prediction of Protein-Ligand Binding Affinity Ìí¼Óµ½ÎÒµÄÈÕ³Ì
»á³¡£º×ۺϽÌѧ2ºÅÂ¥B305 Ö÷³ÖÈË£ºÂ½ÎÄ´Ï£¬Áõ éó
13:30-13:5525-I-016ÀîÓÐÓ¶à³ß¶ÈÄ£Äâ·½·¨µÄ·¢Õ¹¼°ÆäÔÚ¹¦ÄܲÄÁÏÄ£ÄâÖеÄÓ¦ÓÃÌí¼Óµ½ÎÒµÄÈÕ³Ì
13:55-14:2025-I-017½ÎÄ´ÏÊý¾ÝÍÚ¾ò·½·¨¼°ÆäÔÚ²ÄÁÏÉè¼ÆºÍÓÅ»¯ÖеÄÓ¦ÓÃÌí¼Óµ½ÎÒµÄÈÕ³Ì
14:20-14:3525-O-034ÀîÃô½Ü¸ßЧȾÁÏÌ«ÑôÄÜµç³ØÖÐÓлúȾÁÏ·Ö×ÓÉè¼ÆµÄÀíÂÛÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
14:35-14:5025-O-035ÕÔÒ»À×¶àÔª±äÁ¿·½·¨ÔÚÄÉÃ×£­µ°°×ÖÊ£­Ð¡·Ö×Ó»¥×÷¹âÆ×·ÖÎöÖеÄÓ¦Óà Ìí¼Óµ½ÎÒµÄÈÕ³Ì
14:50-15:0525-O-036ÖÜÑàÆ½»ùÓÚÁ£×ÓȺÓÅ»¯µÄÑ¡ÔñÐÔ×ÔÖú¼¯³É·ÖÀàÊ÷Ëã·¨ÓÃÓڷΰ©ÑªÇåµÄ1H NMR´úл×éѧÊý¾Ý·ÖÎöÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
»á³¡£º×ۺϽÌѧ2ºÅÂ¥B305 Ö÷³ÖÈË£ºÀîÏþϼ£¬ÍõÈÎС
15:20-15:4525-I-018ÀîÏþϼ×ÀÃæ»úÉϵĴó¹æÄ£·´Ó¦¶¯Á¦Ñ§Ä£Äâз½·¨Ìí¼Óµ½ÎÒµÄÈÕ³Ì
15:45-16:1025-I-019ÁõéóÊ÷Ðδó·Ö×ÓºÍʯīϩҩÎï´«ÊäϵͳµÄ·Ö×Ó¶¯Á¦Ñ§Ä£ÄâÌí¼Óµ½ÎÒµÄÈÕ³Ì
16:10-16:3525-I-020¹ùºéϼ¸ß·Ö×ÓÌåϵϵͳ´ÖÁ£»¯Ä£Ð͵Ĺ¹½¨£º´ÖÁ£»¯Á¦³¡Î¶ȿÉÇ¨ÒÆÐÔÌí¼Óµ½ÎÒµÄÈÕ³Ì
16:35-17:0025-I-021Ö£Çå´¨AF9ÓëÒÒõ£»¯×éµ°°×Ö®¼äµÄÏ໥×÷ÓûúÖÆÌí¼Óµ½ÎÒµÄÈÕ³Ì
17:00-17:1525-O-037ÀîÑÞÀ¤»ùÓÚģʽʶ±ð·½·¨¶Ô·Î°©»¼Õߺͽ¡¿µÈËѪÇåÀ­Âü¹âÆ×Êý¾ÝµÄ½âÎöÌí¼Óµ½ÎÒµÄÈÕ³Ì
17:15-17:3025-O-038¸¶ºÆºÆÆÏ¾ÛÌÇÁ¬½Ó·½Ê½¶Ô¶àÌÇ-̼ÄÉÃ׹ܸ´ºÏÎï¿Õ¼ä½á¹¹µÄÓ°ÏìÌí¼Óµ½ÎÒµÄÈÕ³Ì
17:30-17:4525-O-039Ñîºë±öС·Ö×ÓÑÇϸ°û¶¨Î»µÄ¼ÆËã»úÔ¤²âÄ£Ð͹¹½¨Ìí¼Óµ½ÎÒµÄÈÕ³Ì
»á³¡£º×ۺϽÌѧ2ºÅÂ¥ Ö÷³ÖÈË£ºÉÛѧ¹ã£¬ÀîÓÐÓÂ
10:05-12:0525-P-001Íõ½¨¹ú¾ßÓп¹½áºË»îÐÔµÄÐÂÐÍAHASÒÖÖÆ¼ÁÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-002Íõ´ä´ä¸»¼¯¼¼ÊõÓÃÓÚ½üºìÍâ¹âÆ×¶¨Á¿·ÖÎö¸´ÔÓÑùÆ·ÖеÄ΢Á¿ÎïÖÊÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-003Íô˫˫ÂÖÍéÖеÄÔ˶¯¡ª¡ª´©Ëó¹ý³ÌÖаéËæ×Å»·ºý¾«µÄ¹¹Ïó±ä»¯Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-004´ÞÏþÓî¶à¼¶Í¬Ê±³É·Ö·ÖÎöÓÃÓÚοؽüºìÍâ¹âÆ×Êý¾ÝµÄ´¦ÀíÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-005ÕÅÇïÀ¼¹âÆ×·¨½áºÏ»¯Ñ§¼ÆÁ¿Ñ§Ñо¿¿×ȸʯÂ̼°Æä´úл²úÎïÓëBSAµÄ×÷ÓÃÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-006ÁõÌ«°º»ùÓÚµç×Ó±ÇÊý¾ÝµÄÖ§³ÖÏòÁ¿»úÔ¤±¨ÖíÈâ¾úÂä×ÜÊýÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-007ФÁÖ»ÔÖ§³ÖÏòÁ¿»Ø¹éÓÃÓÚżµªÈ¾ÁϵÄÇ׺ÍÁ¦Ô¤²âÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-008ÕÅÇì¸ÆîÑ¿ó²ÄÁÏÖÇÄÜÊý¾Ý¿âÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-009¬¿­ÁÁ»ùÓÚÏà¹ØÏòÁ¿»úµÄîÜÂÁ²ã×´Ë«ÇâÑõ»¯Îï·úÀë×ÓÎü¸½ÐÔÄÜÔ¤²âÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-010ÐìäìÔ­×Ó²ÎÊý-Ïà¹ØÏòÁ¿»ú·½·¨ÓÃÓÚ¸ÆîÑ¿óÐÍÀë×Óµ¼ÌåµÄµçµ¼ÂÊÔ¤±¨Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-011»Æå°¾Û¶þ¼×»ù¹èÑõÍéµÄȫԭ×ÓÁ¦³¡ºÍ´ÖÁ£»¯Á¦³¡Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-012ºú±ë²ã×´Ë«½ðÊôÇâÑõ»¯Îï±È±íÃæ»ýµÄÊý¾ÝÍÚ¾òÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-013ÁõÐãçâMC-UVE·¨ÓÃÓÚɸѡÓë°×µ°°×Ïà¹ØµÄ½üºìÍâ±äÁ¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-014¶¡¿¡½Ü±ÍÂé¶¾ËØÓëµ¥Á´¿¹Ìå·Ö×Óʶ±ðÀíÂÛÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-015Àîï¶«»ùÓÚ³¤³ÌÎÞÐòµ°°×Á´³ß´ç¹ØÏµµÄ´ÖÁ£»¯·Ö×Ó¶¯Á¦Ñ§Ä£ÄâÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-016ÍõϼeSHAFTS£º»ùÓÚ·Ö×ÓÈýάÏàËÆÐÔµÄÒ©ÎïÉè¼ÆÍ¼ÐÎÓû§½çÃæÏµÍ³Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-017¸µåûß²ßøÐ¿ÀàÃô»¯¼ÁµÄÀíÂÛÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-018¶ÅººÎļÆËã·½·¨È·ÈÏ3A4±ð¹¹Î»µã²¢·¢ÏÖ±ð¹¹Î»µãÐÂÐÍÒÖÖÆ¼Á¹Ç¼ÜÄ£ÐÍÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-019½ðîȱ½µÄ´ÖÁ£»¯Á¦³¡£º´øµçÄ£ÐÍÓë²»´øµçÄ£ÐͶԱÈÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-020ÍõÓñÀ¼Õë¶ÔSAMÒÀÀµµÄ¼×»ù×ªÒÆÃ¸°Ð±êÌØÒìÐÔ´ò·Öº¯ÊýµÄ·¢Õ¹¼°Ó¦Ó᪡ªDOT1LÒÖÖÆ¼ÁɸѡÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-021Ò¶ÑÞµ°°×Öʾ«°±Ëá¼×»ù»¯×ªÒÆÃ¸£¨PRMT5£©ÐÂÐÍÑ¡ÔñÐÔÒÖÖÆ¼ÁµÄ·¢ÏÖÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-022ÁõÖ¾º£ÏµÍ³ÊÕ¼¯PDBÊý¾Ý¿âÖеÄÇ׺ÏÐÔÊý¾Ý£ºPDBbindÊý¾Ý¿âµÄ×îнøÕ¹Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-023Jie DongBioTriangle: a web service for computing various descriptors of small molecules, proteins, DNAs/RNAs and their interactionsÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-024ÁõÍòǿ֬·¾×åÃÑÀ໯ºÏÎïµ¼ÈÈÂʵ͍Á¿¹¹Ð§¹ØÏµÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-025ҦС¾üHCV NS5B RNAÒÀÀµÐÔRNA¾ÛºÏøͻ±ä¶ÔBMS-791325ÄÍÒ©»úÖÆµÄ·Ö×ÓÄ£ÄâÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-026ÀîÑîHIV-1µ°°×øÒÖÖÆ¼ÁµÄ½á¹¹»îÐÔ¹ØÏµÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-027ҦС¾ü»ùÓÚËæ»ú¼ÓËÙºÍÀ­Éì·Ö×Ó¶¯Á¦Ñ§Ä£ÄâµÄB-RAFÒÖÖÆ¼Á½âÀë·¾¶¼°ÆäÓëÖÍÁôʱ¼äÏà¹ØÐÔµÄÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-028Õ½¾ÃÓîÈ©ÌÇ»¹Ô­Ã¸ÒÖÖÆ¼Á×è°­NADP+À뿪AKR1B1ÍѸ¨»ùøµ°°×Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-029ÍõÀö»¯Ñ§¼ÆÁ¿Ñ§¸¨Öú¸ßЧҺÏàÉ«Æ×-¶þ¼«¹ÜÕóÁмì²âÆ÷ͬʱ²â¶¨ÖÐÒ©è×ʵÖеÄÁùÖÖ»ÆÍªÀ໯ºÏÎïÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-030ÕÅÑ©¼«¶ËÊÈÈȵ°°×Ssh10b¶ÔRNAÈÈÎȶ¨ÐԺ͹¹Ïó±ä»¯Ó°ÏìµÄ·Ö×Ó¶¯Á¦Ñ§Ä£ÄâÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-031ÖìÀö¸ßЧҺÏàÉ«Æ×-¹â¶þ¼«¹ÜÕóÁмì²âÆ÷½áºÏ ½»ÌæÈýÏßÐÔ·Ö½â¶þ½×УÕý·½·¨¿ìËٲⶨ»¯×±Æ·ÖÐËÄÖÖß»à«Ïã¶¹ËØÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-032·½»À»¯Ñ§¼ÆÁ¿Ñ§¶þ½×УÕý½áºÏÈýάӫ¹â¹âÆ×·¨ÓÃÓÚ ºìºµÁ«ÖÐéÎÆ¤ËØÓë«¶¡µÄͬʱ¶¨Á¿·ÖÎöÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-033ËïÃôÕÂÆÏÌÑÌÇתÔ˵°°×µÄתÔËÑ¡ÔñÐÔ¼°ÆäתÔË»úÖÆÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-034ÕÔÎĺ­DJ-1ÒÒ¶þȩøÁ¢Ì嶨Ïò»úÖÆ¼°Æä·´Ó¦»úÀíµÄÀíÂÛÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-035ºúÓÂÓ«¹âÖ¸ÎÆÍ¼Æ×½áºÏ½»ÌæÈýÏßÐÔ·Ö½âËã·¨ºÍģʽʶ±ð·½·¨ÓÃÓÚ²»Í¬Æ·Àà²èÒ¶µÄ·ÖÀàÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-036Íõ×ÓÃñ³ôÑõÑõ»¯½¹»¯·ÏË®ÖзÓÀà·Ö×ÓµÄReaxFF-MDÄ£ÄâÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-037µÔ¶¬·ÐʯBrønstedËáÐÔλ´ß»¯ÐÔÄÜÆÀ¼ÛµÄµÚÒ»ÐÔÔ­ÀíÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-038ËïС¶«Èýάӫ¹â½áºÏ¶þ½×УÕý·½·¨¿ìËÙ¼ì²âÄÌ·ÛÖжàÀà´Æ¼¤ËØÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-039Ð¤ÈØ¼¤·¢·¢É侨ÕóÓ«¹â½áºÏ¶þ½×УÕý·½·¨Í¬Ê±²â¶¨ÈËÌåѪ½¬ÖеĻª·¨ÁֺͰ¢Ë¾Æ¥ÁÖÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-040ÍõͯHPLC-DAD½áºÏ½»ÌæÈýÏßÐÔ·Ö½â¶þ½×УÕý·½·¨Í¬Ê±²â¶¨Æ»¹û¹ûƤ¡¢¹ûÈâ¼°¹ûÔüÖÐÊ®ÖÖ¶à·ÓÀàÎïÖʺ¬Á¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-041ÕÅÔÆÜ߸»µªÔÓ»·º¬ÄÜÀë×ÓÑθжȺͷֽâζȵ͍Á¿¹¹Ð§¹ØÏµÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-042¸ßê¿ÓîºìÍâ¹âÆ×½áºÏ½»»¥Ê½×ÔÄ£ÐÍ»ìºÏÎï·ÖÎöÑо¿ 4-°±»ù-3£¬5-¶þ¼×»ùßÁßòµÄºÏ³É»úÀíÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-043Íõ¹ðÃôÒõÀë×Ó©¤ÒõÀë×ÓÐͱ¼ü×÷ÓõÄÀíÂÛÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-044Àî½ÜadmetSARÍøÕ¾¸üУºÒÔÒ©Îï´úлøתÔËÌå¼°¸Î¶¾ÐÔΪÀýÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-045Íõռ÷һÖÖ»ùÓÚ×ÔÓɶ¨±êµÄ¼¤¹âÓÕµ¼»÷´©¹âÆ×¼¼Êõ(CF-LIBS)½áºÏ¶þ·Ö·¨È·¶¨Ìú¿óʯËá¶ÈµÄз½·¨Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-046ÎâÔøî£Ò»ÖָĽøµÄÍøÂçºÍ»¯Ñ§ÐÅϢѧÇý¶¯µÄ»¯ºÏÎï×÷ÓûúÖÆÊ¶±ð·½·¨Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-047Àî¼ÓÖÒµ°°×Í»±äÒýÆðµÄÐÛ¼¤ËØÊÜÌåÞ׿¹¼ÁÄÍÒ©»úÖÆ¼°ÄÍÒ©Í»±äλµãÔ¤²âÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-048¶¡ÅôTarExplorer: A web server for potential bioactive-small-molecule target prediction through WEGAÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-049ÍõÕÜ10ÖÖ·Ö×Ó¶Ô½Ó³ÌÐò²ÉÑùºÍ´ò·ÖÐÔÄܵÄ×ۺϲâÆÀÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-050ÅËÅ೽Ѫ¹ÜÉú³ÉËØÊÜÌåTie-2С·Ö×ÓÒÖÖÆ¼ÁµÄÐéÄâɸѡÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-051Âí¿¡ÐãÔÚÏߺìÍâ½áºÏ»¥ÐÅÏ¢×îС¶ÀÁ¢³É·Ö·ÖÎö¶Ô3,5-¶þ°±»ù-1,2,4-ÈýßòºÏ³É»úÀíµÄÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-052ãÆ´º»ª¼¤¹âÓÕµ¼»÷´©¹âÆ×¼¼Êõ½áºÏN×î½üÁÚ·¨ÓÃÓÚ²»Í¬Ëá¼îÐÔÌú¿óʯµÄʶ±ðÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-053ÕÔìäTakeoutµ°°×¼Ò×åÅäÌå½áºÏ-ÊÍ·Å»úÖÆµÄ·Ö×ÓÄ£ÄâÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-054À×Ì«ÁúʹÓÃÏà¹ØÏòÁ¿»ú¼°Ò»ÖÂÐÔ½¨Ä£Ô¤²â´óÊó¾­¿Ú¼±ÐÔ¶¾ÐÔÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-055½¶¬Ò©Ô´ÐÔ¼±ÐÔÉöËðÉ˵ĹØÁª°Ð±êÔ¤²âÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-056Õž°¹ãDrug@home£ºÈýά·Ö×ÓÏàËÆÐԵķֲ¼Ê½¼ÆËãÆ½Ì¨Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-057»ÆÐ¡Ç¿Ê¹ÓÃProdaMatchÆ¥ÅäËã·¨ËÑË÷ÓÃÓÚøÉè¼ÆµÄµ°°×ÖʹǼÜÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-058ÀîÖØê½ÐÂÐÍD-A-¦Ð-AÐÍȾÁÏ·Ö×ÓµÄÉè¼ÆÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-059ÍõÇÛ»¯ºÏÎïÑÛ¾¦´Ì¼¤ÐԺ͸¯Ê´ÐԵļÆËã»úÔ¤²âÄ£ÐÍÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-060²Ü»³Çäµ°°×-µ°°×Ï໥×÷ÓÃÖнáºÏÇ׺ÍÐÔÓë½áºÏ¶¯Á¦Ñ§µÄÏ໥ӰÏìÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-061Áõ½Ü¶Ô»ùÓÚµ°°×-ÅäÌ帴ºÏÎï½áºÏÊÆÄÜÃæµÄÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-062ͯÒÀEGFRÑ¡ÔñÐÔÒÖÖÆ¼ÁµÄɸѡÓëÆÀ¼ÛÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-063¶Å²´´¬²»Í¬Ê±¼ä³ß¶ÈϦÁ-°±»ùËáÖ÷Á´¶þÃæ½ÇµÄÏà¹ØÐÔÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-064±åÏ£»Û½üºìÍâ¹âÆ×½áºÏ»¯Ñ§Ä£Ê½Ê¶±ð¶ÔÏàËÆÖÐÒ©²ÄµÄ¼ø±ðÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-065ÀîÊç¾êBoosting¼«ÏÞѧϰ»úÓÃÓÚ¸´ÔÓÑùÆ·¹âÆ×¶¨Á¿·ÖÎö·½·¨Ñо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-066ÉêÓÂÁ¢Cu/¦Â·Ö×Óɸ±íÃæ¼×Ëá¼×õ¥¼°¼×Ñõ»ù¼×ÍéÉú³É»úÀíµÄDFTÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-067ºÎ¼ÑÓ¦±äЧӦºÍÅäλЧӦ¶Ô¶þÑõ»¯Ì¼ÔÚPd±íÃæµç»¹Ô­ÐÔÄܵÄÓ°ÏìÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-068ÁõêÍCaFE:Ò»ÖÖ»ùÓÚÁ½µãʽ×ÔÓÉÄÜ·½·¨µÄÇ׺ÍÁ¦Ô¤²â¹¤¾ßÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-069Ìï¿­»ÆÍªÀàÑÜÉúΰ©»îÐԵķÖ×Ó¶Ô½Ó¡¢·Ö×Ó¶¯Á¦Ñ§Ä£Ä⠺Ͷ¨Á¿¹¹Ð§¹ØÏµÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-070ÕÅÑÇÃÄ´øn-Íé»ùÁ´Î²°ÍµÄ߲߸·Ö×ÓµÄÕûÁ÷Æ÷Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-071ÕÅÎÄæÃÀíÂÛ̽¾¿Ì¼ÅðÍéµÄÒýÈë¶Ô²¬ÅäºÏÎïµç×ӽṹºÍ¹âÎïÀíÐÔÄܵÄÓ°ÏìÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-072ÇØÅô·ÉÊÖ»úÉϵĻùÒò²âÐò·ÖÎöºÍ½â¶ÁϵͳMyGeneÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-073ÌÕ¿¡»ùÓÚϸ°ûÉ«ËØbc1¸´ºÏÎïµÄÐéÄâɸѡÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-074Îâ·áÐñAUTO_CMS£ºÒ»ÖÖÐÂÐÍÒ©ÎÐÔÔ¤²âÍøÂç·þÎñÆ÷Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-075Ñî¾°·¼»ùÓÚÉú³¤ËØÊÜÌåTIR1µÄÐéÄâɸѡÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-076ÓÚÓñç÷HIV-1 µ°°×ø¹¹Ïó±ä»¯»úÖÆ¼°¿¹Ò©ÐÔÍ»±äµÄÓ°ÏìÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-077½­ÎÄÒ»ÖÂÐÔ·½·¨ÊµÏָ߾«¶È·Ö×Ó¶Ô½ÓÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-078¿×ÏþÌìà×à¤ÀàÒÖÖÆ¼ÁÓëCDK2ºÍCDK9Ñ¡ÔñÐÔ½áºÏ»úÀíµÄÀíÂÛÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-079ÕÅÔÆÜ߸»µªÔÓ»·º¬ÄÜÀë×ÓÑθжȺͷֽâζȵ͍Á¿¹¹Ð§¹ØÏµÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-080Íò¼áTNP-AMPÓëHu-FBPase½áºÏģʽµÄÐÂÈÏʶÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-081ÈÎÑåÁÁ¹ûÌÇ1,6-¶þÁ×ËáÈ©Ëõø(FBA-II) ÐÂÐÍÒÖÖÆ¼ÁµÄºÏÀíÉè¼ÆÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-082ÕÔµ¤PTP1BÒÖÖÆ¼ÁµÄ½áºÏģʽÓëÐéÄâɸѡÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-083¹ùçø½üºìÍâ¹âÆ×·¨½áºÏ»¯Ñ§¼ÆÁ¿Ñ§·½·¨¼ø±ðɽҩ·Û¼°Æä²ôÔÓÆ·Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-084²Ìæ¼»ùÓÚ»úÆ÷ѧϰµÄDPP-IVÒÖÖÆ¼ÁµÄÐéÄâɸѡÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-085Shaoyong LuThe Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4BÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-086ÍõÓÀÌÎÂÈ»¯ÑÇÍ­´ß»¯µÄ2,3,6-Èý¼×»ù±½·ÓÑõÆøÑõ»¯·´Ó¦»úÀíµÄÁ¿»¯¼ÆËãÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-087Yanli WangG-Quadruplex Stabilizer: Design, Synthesis and Anti-tumor Activity of Benzoheteroxanthene DerivativesÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-088ÁõÊÀ¶÷PGAM1µÄC¶Ë¹¹Ïó±ä»¯¼°¹¦ÄܵļÆËãÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-089×Þ³¬·æ¶àÔªÇúÏß·Ö±æÔ¤²âÁ÷¶¯ÆøÌåŨ¶ÈºÍ´«¸ÐÆ÷Ðźű仯Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-090³ÂÑþ¸´ÔÓ¶àÏàÌåϵµÄ±íÃæÔöÇ¿À­Âü¹âÆ×׼ȷ¶¨Á¿·ÖÎö·½·¨Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:3025-P-091֣Ĭ»ùÓÚ¶àGPUµÄReaxFF MD²¢ÐвßÂÔµÄÉè¼ÆºÍʵÏÖÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-092¶Å´ÔÃôÌ«ºÕ×ȹâÆ×¼¼Êõ½áºÏ»¯Ñ§¼ÆÁ¿Ñ§·½·¨¶¨Á¿·ÖÎöÈý×é·Öͬ·ÖÒìÌå»ìºÏÎïÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-093ÁõÖ¾½»ÌæÈýÏßÐԷֽ⸨ÖúLC-MSÒÔÌá¸ß·ÖÎöÑ¡ÔñÐÔºÍÁéÃô¶ÈÓÃÓÚÈ¥¸ÉÈŵزⶨ¹ÈÎïÖжàÀàù¶¾Ëغ¬Á¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-094ÆÑѩ÷A novel strategy applied to simultaneously determination on TNT and DNT isomers in natural water: a combination of UV-Vis spectrum and chemometricsÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-095ÆÑѩ÷Exploring the mechanism of the mutation-caused constitutive activity of GPCR by a computational studyÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-096Ëï»ÛÓ¿¸ß¾«¶ÈMIEC-SVMÄ£Ð͵Ĺ¹½¨¼°ÆäÔÚÐéÄâɸѡÖеÄÓ¦ÓÃÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-097²Ü·çÀׯøÌåС·Ö×Óº¬ìع±Ï×´ÖÁ£»¯Á¦³¡µÄ¿ª·¢ºÍÓ¦ÓÃÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-098ÎâÁá»ùÓÚ·´Ó¦¹æÔòµÄÉúÎïºÏ³É;¾¶Éè¼ÆÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-099ÕÔ̸·â°¢×¿ÌÇ»·ºý¾«¼°ÆäÑÜÉúÎïµÄÌǵ¥ÔªÔÚ°ü½á¹ý³ÌÖеĹ¹Ïó±ä»¯Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-100лÀöϼÈýÏßÐÔ·Ö½âΨһÐÔÓ¦ÓÃ̽Ë÷£ºÐµÄÖȹÀ¼Æ·½·¨Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-12:0525-P-111¹È»ÝÎÄ»ùÓÚÀ©Ôö¾ØÕóÐÎʽµÄ½»ÌæÈýÏßÐÔ·Ö½âËã·¨ÓÃÓÚ·ÖÎö·ÇËÄÏßÐÔËÄάÊý¾ÝÌí¼Óµ½ÎÒµÄÈÕ³Ì
2016-07-04
»á³¡£º×ۺϽÌѧ2ºÅÂ¥B305 Ö÷³ÖÈË£º¼ÍÖ¾Áº£¬³Â ´ï
09:00-09:2525-I-022Zhiliang JiRapid Drug Safety Assessment in the Big Data EraÌí¼Óµ½ÎÒµÄÈÕ³Ì
09:25-09:5025-I-023»ÆÏàÖлÆÍªÀàÑÜÉúΰ©»îÐԵķÖ×Ó¶Ô½Ó¡¢·Ö×Ó¶¯Á¦Ñ§Ä£Ä⠺Ͷ¨Á¿¹¹Ð§¹ØÏµÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
09:50-10:0525-O-040ÐÏæºBRD4רÓÃÐéÄâɸѡ´ò·Öº¯ÊýBRD4LGR£º·¢Õ¹¼°Ó¦ÓÃÌí¼Óµ½ÎÒµÄÈÕ³Ì
10:05-10:2025-O-041ÍõÀöÀö»¯Ñ§¼ÆÁ¿Ñ§·½·¨ÔÚ½üºìÍâ¹âÆ×·ÖÎöÖеÄÓ¦ÓÃÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
10:20-10:3525-O-042ÁõÄÈÍØÆËÒ칹øII´ß»¯ÐÔÒÖÖÆ¼ÁµÄÐéÄâɸѡºÍÉúÎï»îÐÔÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
»á³¡£º×ۺϽÌѧ2ºÅÂ¥B305 Ö÷³ÖÈË£ºËï »´£¬ÙÚ½¨²¨
10:50-11:1525-I-024Ëï»´·Ö×Ó¶¯Á¦Ñ§Ä£Ä⻯ѧ·´Ó¦ÖеÄÔöÇ¿²ÉÑù·½·¨Ñо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
11:15-11:4025-I-025ÙÚ½¨²¨»ùÓÚCoMFA¡¢CoMSIA¶ÔëÄÀàÒ©ÎïµÄQSARÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
11:40-11:5525-I-026Ö£¹úÑ«»ùÓÚ·Ö×Ó¶¯Á¦Ñ§Ä£Äâ·½·¨Ì½¾¿Ñ¡ÔñÐÔÈ¥¼×ÉöÉÏÏÙËØÖØÉãÈ¡ÒÖÖÆ¼ÁµÄ×÷ÓûúÖÆÌí¼Óµ½ÎÒµÄÈÕ³Ì
11:55-12:1025-O-043¸ß˧ʦÀûÓÃת¼×éÊý¾ÝÍÆ¶Ï°©Ï¸°ûµÄ´úлĿ±êÌí¼Óµ½ÎÒµÄÈÕ³Ì
»á³¡£º×ۺϽÌѧ2ºÅÂ¥B305 Ö÷³ÖÈË£ºÒ¦½¨»ª£¬³ÂÔöƼ
13:30-13:5525-I-027Ò¦½¨»ªº£Á¿»¯ºÏÎïÊý¾ÝµÄ·ÖÎö²ßÂÔ³õ̽Ìí¼Óµ½ÎÒµÄÈÕ³Ì
13:55-14:2025-I-028³ÂÔöƼ·Ç¾ùÏàÌåϵӫ¹â»¯Ñ§/ÉúÎï´«¸Ð¼¼ÊõÖеĻ¯Ñ§¼ÆÁ¿Ñ§ÀíÂÛ¼°Ó¦ÓÃÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
14:20-14:3525-I-029ÕÅÏþͮȼÁÏÓÍÖÐÓлúÁò»¯ÎïÔÚ²»Í¬É«Æ×ÖùÉÏµÄÆøÏàÉ«Æ×±£ÁôÐÐΪ¡ª¡ª¶¨Á¿½á¹¹É«Æ×±£Áô¹ØÏµ(QSRR)µÄÑо¿Ìí¼Óµ½ÎÒµÄÈÕ³Ì
14:35-14:5025-I-030Ì·¾ý7¦Á-ôÇ»ùÀà¹Ì´¼ÍÑÇâø¾§Ìå½á¹¹Öи¨Ã¸NADP(H)µÄʶ±ðλµã·ÖÎöÌí¼Óµ½ÎÒµÄÈÕ³Ì
14:50-15:0525-O-044Áõçæ»ùÓÚÈ«»ùÒò×éµÄÁÙ´²Ò©Îï²»Á¼·´Ó¦ÆÀ¹ÀÌí¼Óµ½ÎÒµÄÈÕ³Ì
»á³¡£º×ۺϽÌѧ2ºÅÂ¥B305 Ö÷³ÖÈË£º¶Åһƽ£¬µÔºìÁÖ
15:20-15:4525-I-031µÔºìÁÖ»ùÓÚÈýÎ¬Ö¸ÎÆÍ¼Æ×µÄÖÐÒ©ÖÊ¿ØÐ·½·¨Ìí¼Óµ½ÎÒµÄÈÕ³Ì
15:45-16:1025-I-032¶Åһƽ¹ÌÏàÝÍÈ¡¹âÆ×·¨½áºÏ¶àԪУÕýͬʱ²â¶¨Ë®ÖкÛÁ¿½ðÊôÀë×ÓÌí¼Óµ½ÎÒµÄÈÕ³Ì
16:10-16:3525-I-033³Â´ï»ùÓÚÖÇÄܹâÆ×´«¸Ð¼¼ÊõµÄÈéÖÆÆ·²ôÔÓ¿ìËÙɸ²éÌí¼Óµ½ÎÒµÄÈÕ³Ì
16:35-17:0025-I-034Î⺣Áú»¯Ñ§¶àάУÕý·½·¨ÀíÂÛÓëÓ¦ÓÃÑо¿Ð½øÕ¹Ìí¼Óµ½ÎÒµÄÈÕ³Ì
»á³¡£º×ۺϽÌѧ2ºÅÂ¥B305 Ö÷³ÖÈË£º·Ö»á°ä½±¼°±ÕÄ»--Î⺣Áú

¡¡¡¡±¨¸æ¡¶¡·£¬Ä¿Ç°ÄúµÄÈճ̱íÖй²Óиö±¨¸æ¡£

¡¡

½ØÖ¹ÈÕÆÚ

»áÒé×¢²á£º2016Äê5ÔÂ15ÈÕ

ÂÛÎÄÕ÷¼¯£º2016Äê4ÔÂ15ÈÕ

»áǰ½É·Ñ£º2016Äê5ÔÂ15ÈÕ

Íü¼ÇÃÜÂë

Öйú»¯Ñ§»áÃØÊé´¦

µØ¡¡¡¡Ö·£º±±¾©ÊÐÖйش山һ½Ö2ºÅ
ÁªÏµµç»°£º+86-10-82449177
ÓÊÕþ±àÂ룺100190


´«¡¡¡¡Õ棺+86-10-62568157
Íø¡¡¡¡Ö·£ºhttp://www.chemsoc.org.cn


¸öÈË»áÔ±£ºqiaoqinzhao@iccas.ac.cn
ѧÊõ½»Á÷£ºcmdeng@iccas.ac.cn
¹ú¼ÊÊÂÎñ£ºhanlidong@iccas.ac.cn
»¯Ñ§¾ºÈü£ºwlbai@iccas.ac.cn


ѧÊõ½±Àø£ºyuehe@iccas.ac.cn
ÆÚ¡¡¡¡¿¯£ºhaolinxiao@iccas.ac.cn
µ¥Î»»áÔ±£ºwangyr@iccas.ac.cn
²úѧÑкÏ×÷Óë´Ù½ø£ºbinjiao@iccas.ac.cn


All Rights Reserved by the Chinese Chemical Society¡¡Öйú»¯Ñ§»á °æÈ¨ËùÓÐ ¾©ICP±¸05002797ºÅ

ÃÅ»§ÍøÕ¾¡¢»áԱϵͳ¡¢»áÒéϵͳ ¼¼ÊõÖ§³Ö£ºÉîÛÚÊÐѧÊõ¿Æ¼¼ÓÐÏÞ¹«Ë¾ www.szac.cn

Baidu
map